PinnyPeptide

Adamax vs PE22-28

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Adamax

Cognitive

Adamantyl-capped Semax derivative — a more lipophilic, longer-acting nootropic analog.

Peptide B

PE22-28

Cognitive

Fast-acting antidepressant peptide acting via TREK-1 channel inhibition.

Typical vial

5 mg

Typical dose

100-500 mcg

Half-life

Estimated longer than Semax (~hours, uncharacterized)

FDA status

Not FDA approved.

Typical vial

5 mg

Typical dose

50-200 mcg

Half-life

Hours; precise value species-dependent

FDA status

Not FDA approved.

Adamax effects

  • Hypothesized BDNF upregulation in hippocampus / cortex
  • Theoretical longer duration of action vs. Semax
  • Theoretical improved blood-brain barrier penetration
  • Cognitive enhancement claims (attention, memory)
  • Mood and stress-resilience effects (extrapolated from Semax)

PE22-28 effects

  • Selective TREK-1 potassium channel inhibition
  • Fast-onset antidepressant-like effects in rodent models
  • Increased serotonergic neuron firing in dorsal raphe
  • Enhanced BDNF / TrkB signaling downstream
  • Anti-anxiety effects in some assays

Adamax side effects

  • Largely uncharacterized in published literature
  • By analogy with Semax: mild headache, sleep disturbance, irritability at high doses
  • Theoretical: adamantyl-related effects on dopamine signaling
  • Injection-site or intranasal irritation

PE22-28 side effects

  • Essentially uncharacterized in humans
  • Theoretical: TREK-1 inhibition off-target in heart, immune cells
  • Subjective reports of mood activation, occasional anxiety
  • Injection-site reactions
  • Sleep disturbance with late-day dosing

Adamax dosing ranges

Cognitive research (intranasal)

100-300 mcg · Once or twice daily · 14-30 days per cycle

Subcutaneous research

100-500 mcg · Once daily · 14-30 days per cycle

PE22-28 dosing ranges

Antidepressant research (preclinical)

100-500 mcg/kg · Daily SubQ or IP · Per protocol

Self-experimentation (no clinical guidance)

50-200 mcg · Once or twice daily · 2-4 weeks per cycle

Adamax vs PE22-28 — common questions

What is the difference between Adamax and PE22-28?

Adamax: Adamantyl-capped Semax derivative — a more lipophilic, longer-acting nootropic analog. Typical dose 100-500 mcg. PE22-28: Fast-acting antidepressant peptide acting via TREK-1 channel inhibition. Typical dose 50-200 mcg. Both fall under the Cognitive category.

Can you stack Adamax and PE22-28?

Stacking Adamax with PE22-28 is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Adamax or PE22-28?

Adamax is typically dosed: Once or twice daily for Cognitive research (intranasal); Once daily for Subcutaneous research. PE22-28 is typically dosed: Daily SubQ or IP for Antidepressant research (preclinical); Once or twice daily for Self-experimentation (no clinical guidance).

Are Adamax and PE22-28 FDA approved?

Adamax: Not FDA approved. PE22-28: Not FDA approved.

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free